Medical management versus chemical cautery with medical management in treatment of inferior turbinate hypertrophy: a comparative study
Keywords:Nasal blockage, Inferior turbinate hypertrophy, Medical management, Chemical cautery
Patients having inferior turbinate hypertrophy causing intractable sneezing, rhinnorhoea which is non-responsive to conventional medication require alternative therapies. Aim of the study was to compare medical management vs chemical cautery with medical management in treatment of inferior turbinate hypertrophy since both these treatments are easily accessible, cost effective to the patients as well as not associated with major complications. The complaints sneezing, rhinorrhoea, nasal blockage, headache, eye irritation and redness of patients are reduced and quality of life of patients improved after chemical cautery with medical management as compared to medical management alone. 50 patients of age group 15-75 years with c/o Sneezing, rhinorrhoea, nasal blockage and headache were included in our study. Inferior turbinate hypertrophy was diagnosed on the basis of anterior rhinoscopy and diagnostic nasal endoscopy. Patients were divided randomly in 2 group-group A (medical management), group B (chemical cautery with medical management). The 22 question sino-nasal outcome test (SNOTT22) score and rhinomanometry was done before and after treatment to compare the efficacy and detect symptom free period in both groups. Percentage of relief was more among group B patients as compared to group A patients. Symptom free period was more in group B patients as compared to group A patients and both of them were analysed on the basis of SNOTT22 score and rhinomanometry. Chemical cautery with topical application of silver nitrate coupled with medical management is more effective in treatment of inferior turbinate hypertrophy as compared to medical management alone.
Clement WA, White PS. Trends in turbinate surgery literature: a 35-year review. Clin Otolaryngol Allied Sci. 2001;26(2):124-8.
Leong SC, Eccles R. Inferior turbinate surgery and nasal airflow: evidence-based management. Curr Opin Otolaryngol Head Neck Surg. 2010;18(1):54-9.
Husain Q, Hoehle L, Phillips K, Caradonna DS, Gray ST, Sedaghat AR. The 22-Item Sinonasal Outcome Test as a Tool for the Assessment of Quality of Life and Symptom Control in Allergic Rhinitis. Am J Rhinol Aller. 2020;34(2):209-16.
Demirbas D, Cingi C, Cakli H, Kaya E. Use of rhinomanometry in common rhinologic disorders. Expert Rev Med Devices. 2011;8(6):769-77.
Laurence DR. Sclerosing agents act by causing local inflammation and coagulation. Clin Pharmacol 4th edition. Churchill Livingstone, 1973;13-20.
Bhargava KB, Shirali GN, Abhyankar US, Gadre KC. Treatment of allergic and vasomotor rhinitis by the local application of different concentrations of silver nitrate. J Laryngol Otol. 1992;106:699-701.
Bhargava KB, Abhyankar US, Shah TM. Treatment of allergic and vasomotor rhinitis by the local application of silver nitrate. J Laryngol Otol. 1980;94:1025-36.
al-Samarrae SM, Treatment of 'vasomotor rhinitis' by the local application of silver nitrate. J Laryngol Otol. 1991;105:285-7.
Joy N, Jacob J, Kurien R, Varghese L, Rabi S, Rupa V. Effect of Silver Nitrate Cauterisation of Nasal Mucosa on Quality-of-Life and Histology in Patients with Intractable Chronic Rhinitis. Indian J Otolaryngol Head Neck Surg. 2022;74(2):1615-22.